[324 Pages Report] Booming at an impressive CAGR of 4.7%, the global gamma linolenic acid market is projected to grow from a valuation of US$ 20 million in 2022 to US$ 31.6 million by 2032.
The demand for gamma linolenic acid is surging globally owing to the increasing adoption of healthy lifestyle amongst consumers. Gamma linolenic acid acts as omega-6 which is essential for maintaining heart health. Gamma linolenic acid can be integrated organically by humans, or several food ingredients can be consumed to meet the desired requirements.
| Report Attribute | Details |
|---|---|
| Gamma Linolenic Acid Market Value (2022) | US$ 20 Million |
| Gamma Linolenic Acid Market Anticipated Forecast Value (2032) | US$ 31.6 Million |
| Gamma Linolenic Acid Market Projected Growth Rate (2022-2032) | 4.7% |
The sales of Gamma Linolenic Acid (GLA) are surging due to its several medicinal properties. Gamma linolenic acid is polyunsaturated fatty substance and has a vital function in maintaining human health. This substance is found in several plant seed oils such as evening primrose, borage, and black currant.
There is an increase in the demand for gamma linolenic acid as majority population use this substance for conditions such as eczema (atopic dermatitis), diabetes (diabetic neuropathy), high blood pressure, arthritis, and several other health conditions. However, there exists no firm scientific evidence to back these uses and their effectiveness.
Our body does not generate omega-6 fatty acids, and therefore, they are obtained through various supplements and diets. Besides heart health, omega-6 fatty acids are also used for insulin utilization and mood balance. When gamma linolenic acid is consumed, the body converts it into a particular which alleviates any inflammation.
The gamma linolenic acid market growth is flourishing owing to its use in several industries and in pharmaceutical, dietary supplements, animal nutrition, cosmetics, and food and beverage industries.
Gamma linolenic acid is used in the treatment of medical conditions such as high cholesterol, metabolic syndrome, diabetic nerve pain, chronic fatigue syndrome, deficit-hyperactivity disorder, and for polyps in the mouth.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Rising prevalence of rheumatoid arthritis is predicted to promote the demand for gamma linolenic acid, and this is helping the growth of global gamma linolenic acid market. In 2017, the Arthritis Foundation published a study which stated that approximately 54.4 million Americans are suffering from doctor-diagnosed arthritis.
In arthritis, swelling and pain in joints is the most common symptoms. In such cases, consuming gamma linolenic acid is an effective option as it decreases inflammation and helps in preventing arthritis. Amongst the global consumers awareness related to health is on the rise and there has been a huge alteration in their lifestyle. This factor is said to boost the growth of gamma linolenic acid market.
Nowadays, consumers are preferring products which have natural and nutritive ingredients and offer health benefits. Therefore, as the number of arthritis cases increases, the demand for gamma linolenic acid induced products is anticipated to rise.
Since the human body does not synthesize gamma linolenic acid, we must rely on external sources to meet the requirements of the human body. There occur some metabolic changes in the body due to the deficiency of gamma linolenic acid. Hence, the reliance on external source to fulfil the gamma linolenic acid requirement is anticipated to be one of the factors responsible for the growth of global gamma linolenic acid market.
During the forecast period, the market share of gamma linolenic acid is said to flourish owing to its numerous health benefits. This substance is also used as a medication in several health conditions such as menopause, eczema, and allergies. Moreover, consuming gamma linolenic acid reduces the symptoms associated with nerve damage in diabetic patients.
Certain studies have proven that gamma linolenic acid assists in slowing the tumour growth and additionally helps in enhancing the effectiveness of some anti-cancer drugs. All these abundant benefits of this substance are projected to rise the demand in the pharmaceutical and dietary supplement.
In some cases, side effects linked to the over consumption of gamma linolenic acid could be a restraining factor of the global market.
The Arthritis Foundation says that by the year 2040, the number of individuals in the United States suffering from doctor-diagnosed arthritis is forecasted to increase by 49% and impact nearly 78.4 million population in the U.S. The increasing prevalence of arthritis in North America is anticipated to have a lucrative impact on the gamma linolenic acid market.
From the past few years, the U.S. and European based cosmetic manufacturers have been striving to raise their profit margins. One of the prime business tactics followed by them is business process outsourcing.
Developing countries like India, China, Indonesia, etc., in the Asia Pacific regions have been proven to be production hubs by most of the pharmaceutical and cosmetic manufacturers. This has resulted in the demand for raw materials in this region. Gamma linolenic acid finds its major demand in the Asia Pacific markets.
Principal Consultant
A few of the key players in the gamma linolenic acid market include Merck KGaA, Enzo Life Sciences, Inc., Cayman Chemical, Thermo Fisher Scientific, Cherish Pharma, Changsha Vigorous-Tech, Charkit Chemical, Penta Manufacturing, Acme, Cailà & Parés.
In January 2022, the world leader in serving science, Thermo Fisher Scientific Inc., and Pepro Tech, Inc., announced its acquisition of Pepro Tech in December 2021, for a total cash purchase price of around $1.85 billion.
Market manufacturers of many industries are said to aim on creating products which assist in delivering an efficient solution for arthritis. The manufacturers of gamma linolenic acid have opportunities to enhance the promotional and marketing strategies. This will result in more awareness pertaining to health benefits of gamma linolenic acid and additionally increase its use in several end use industries.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 3.4% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global gamma linolenic acid market is set to advance at a CAGR of 4.7% from 2022 to 2032.
Gamma linolenic acid market is projected to hold a market share of US$ 31.6 million by 2032.
Some of the key players holding major global gamma linolenic acid market share are Merck KGaA, Enzo Life Sciences, Inc., Cayman Chemical, Thermo Fisher Scientific, Cherish Pharma, Changsha Vigorous-Tech, Charkit Chemical, Penta Manufacturing, Acme, Cailà & Parés.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By Nature 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Nature, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Nature, 2022-2032 5.3.1. Organic 5.3.2. Conventional 5.4. Y-o-Y Growth Trend Analysis By Nature, 2017-2021 5.5. Absolute $ Opportunity Analysis By Nature, 2022-2032 6. Global Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By Form 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Form, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Form, 2022-2032 6.3.1. Powder 6.3.2. Liquid 6.4. Y-o-Y Growth Trend Analysis By Form, 2017-2021 6.5. Absolute $ Opportunity Analysis By Form, 2022-2032 7. Global Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By End-use 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By End-use, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By End-use, 2022-2032 7.3.1. Food and Beverage 7.3.2. Dietary Supplements and Functional Foods 7.3.3. Pharmaceutical Industry 7.3.4. Cosmetic and Personal Care 7.3.5. Animal Nutrition 7.4. Y-o-Y Growth Trend Analysis By End-use, 2017-2021 7.5. Absolute $ Opportunity Analysis By End-use, 2022-2032 8. Global Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Region, 2017-2021 8.3. Current Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. East Asia 8.3.5. South Asia & Pacific 8.3.6. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Nature 9.2.3. By Form 9.2.4. By End-use 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Nature 9.3.3. By Form 9.3.4. By End-use 9.4. Key Takeaways 10. Latin America Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Mexico 10.2.1.2. Brazil 10.2.1.3. Rest of Latin America 10.2.2. By Nature 10.2.3. By Form 10.2.4. By End-use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Nature 10.3.3. By Form 10.3.4. By End-use 10.4. Key Takeaways 11. Europe Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. Italy 11.2.1.3. France 11.2.1.4. U.K. 11.2.1.5. Spain 11.2.1.6. BENELUX 11.2.1.7. Russia 11.2.1.8. Rest of Europe 11.2.2. By Nature 11.2.3. By Form 11.2.4. By End-use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Nature 11.3.3. By Form 11.3.4. By End-use 11.4. Key Takeaways 12. East Asia Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Nature 12.2.3. By Form 12.2.4. By End-use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Nature 12.3.3. By Form 12.3.4. By End-use 12.4. Key Takeaways 13. South Asia & Pacific Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. India 13.2.1.2. ASEAN 13.2.1.3. Australia and New Zealand 13.2.1.4. Rest of South Asia & Pacific 13.2.2. By Nature 13.2.3. By Form 13.2.4. By End-use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Nature 13.3.3. By Form 13.3.4. By End-use 13.4. Key Takeaways 14. MEA Gamma Linolenic Acid Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. Turkey 14.2.1.3. South Africa 14.2.1.4. Rest of MEA 14.2.2. By Nature 14.2.3. By Form 14.2.4. By End-use 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Nature 14.3.3. By Form 14.3.4. By End-use 14.4. Key Takeaways 15. Key Countries Gamma Linolenic Acid Market Analysis 15.1. U.S. 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2021 15.1.2.1. By Nature 15.1.2.2. By Form 15.1.2.3. By End-use 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2021 15.2.2.1. By Nature 15.2.2.2. By Form 15.2.2.3. By End-use 15.3. Mexico 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2021 15.3.2.1. By Nature 15.3.2.2. By Form 15.3.2.3. By End-use 15.4. Brazil 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2021 15.4.2.1. By Nature 15.4.2.2. By Form 15.4.2.3. By End-use 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2021 15.5.2.1. By Nature 15.5.2.2. By Form 15.5.2.3. By End-use 15.6. Italy 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2021 15.6.2.1. By Nature 15.6.2.2. By Form 15.6.2.3. By End-use 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2021 15.7.2.1. By Nature 15.7.2.2. By Form 15.7.2.3. By End-use 15.8. U.K. 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2021 15.8.2.1. By Nature 15.8.2.2. By Form 15.8.2.3. By End-use 15.9. Spain 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2021 15.9.2.1. By Nature 15.9.2.2. By Form 15.9.2.3. By End-use 15.10. BENELUX 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2021 15.10.2.1. By Nature 15.10.2.2. By Form 15.10.2.3. By End-use 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2021 15.11.2.1. By Nature 15.11.2.2. By Form 15.11.2.3. By End-use 15.12. China 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2021 15.12.2.1. By Nature 15.12.2.2. By Form 15.12.2.3. By End-use 15.13. Japan 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2021 15.13.2.1. By Nature 15.13.2.2. By Form 15.13.2.3. By End-use 15.14. South Korea 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2021 15.14.2.1. By Nature 15.14.2.2. By Form 15.14.2.3. By End-use 15.15. India 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2021 15.15.2.1. By Nature 15.15.2.2. By Form 15.15.2.3. By End-use 15.16. ASEAN 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2021 15.16.2.1. By Nature 15.16.2.2. By Form 15.16.2.3. By End-use 15.17. Australia and New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2021 15.17.2.1. By Nature 15.17.2.2. By Form 15.17.2.3. By End-use 15.18. GCC Countries 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2021 15.18.2.1. By Nature 15.18.2.2. By Form 15.18.2.3. By End-use 15.19. Turkey 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2021 15.19.2.1. By Nature 15.19.2.2. By Form 15.19.2.3. By End-use 15.20. South Africa 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2021 15.20.2.1. By Nature 15.20.2.2. By Form 15.20.2.3. By End-use 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Nature 16.3.3. By Form 16.3.4. By End-use 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Merck KGaA 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. Enzo Life Sciences, Inc. 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Cayman Chemical 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Thermo Fisher Scientific 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Cherish Pharma 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. ACME 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Caila and Pares 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. DSM 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. Synerzine 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Food and Beverage Insights
View Reports
Gamma Linolenic Acid Market
